Award
Delivery Order #SPE2D326F6619
Delivery Order for Diphenhydramine from Fresenius Kabi under Indefinite Delivery Contract
Buyer
Defense Logistics Agency
Award Amount
$23.37
Ceiling
$23.37
Awarded
February 26, 2026
Period of Performance
Feb 26, 2026 – Feb 27, 2026
Identifier
SPE2D326F6619
NAICS
325411
This award represents a delivery order contract granted to Fresenius Kabi, LLC, a company specializing in pharmaceutical manufacturing and distribution. The order concerns the procurement of Diphenhydramine 50 MG/ML vials, a critical medical supply used for allergy relief and medical treatment. This contract is a component of a larger, ongoing indefinite delivery indefinite quantity (IDIQ) agreement that supports the U.S. Department of Defense's medical readiness by ensuring a steady supply of essential pharmaceuticals. The delivery order specifies a short-term performance period, underscoring timely delivery within a one-day window. The contract was awarded under the existing IDIQ contract, which was competitively bid, reflecting careful sourcing to meet defense healthcare demands reliably. While this contract is focused on a specific medication delivery, it contributes to the broader effort of sustaining military medical operations through consistent pharmaceutical availability. This award does not disclose key subcontractors or detailed solicitation data but is directly linked to the parent indefinite delivery contract that extends through 2030, demonstrating a long-term commitment to supporting the health infrastructure of the U.S. Armed Forces.
Description
4571025536!DIPHENHYDRAMINE 50 MG/ML VIALML